Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AIM AIM ImmunoTech	$2.65 +3.1%	$7.21	$2.46 ▼ $39.95	$2.03M	0.88	66,464 shs	54,241 shs
GMN GobiMin	C$1.83	C$1.83	C$0.20 ▼ C$1.84	C$89.78M	0.76	28,832 shs	167,000 shs
OLY Olympia Financial Group	C$131.20 +1.9%	C$122.48	C$95.51 ▼ C$132.00	C$315.71M	0.27	1,932 shs	1,743 shs
XLY Consumer Discretionary Select Sector SPDR Fund	$229.04 -0.2%	$219.68	$173.10 ▼ $240.28	$23.00B	1.18	4.46 million shs	4.67 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AIM AIM ImmunoTech	0.00%	+6.00%	-69.38%	-71.01%	-90.19%
GMN GobiMin	0.00%	0.00%	0.00%	0.00%	0.00%
OLY Olympia Financial Group	0.00%	+5.59%	+6.67%	+22.62%	+22.62%
XLY Consumer Discretionary Select Sector SPDR Fund	0.00%	+2.35%	+4.01%	+5.22%	+29.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AIM AIM ImmunoTech	1.3699 of 5 stars	3.5	0.0	0.0	0.0	2.0	0.0	0.0
GMN GobiMin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OLY Olympia Financial Group	2.9399 of 5 stars	2.5	0.0	2.5	0.0	1.7	3.3	1.3
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AIM AIM ImmunoTech	3.00	Buy	$275.00	10,277.36% Upside
GMN GobiMin	0.00	N/A	N/A	N/A
OLY Olympia Financial Group	3.00	Buy	C$147.91	12.74% Upside
XLY Consumer Discretionary Select Sector SPDR Fund	2.67	Moderate Buy	$229.04	N/A

Current Analyst Ratings Breakdown

Latest GMN, OLY, AIM, and XLY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/21/2025	OLY Olympia Financial Group	Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy	C$147.91

(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AIM AIM ImmunoTech	$146K	13.87	N/A	N/A	$0.20 per share	13.25
GMN GobiMin	C$28.61K	3,137.84	C$3.22 per share	0.57	C$1.89 per share	0.97
OLY Olympia Financial Group	C$102.64M	3.08	C$11.25 per share	11.66	C$16.72 per share	7.85
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AIM AIM ImmunoTech	-$28.96M	-$24.68	N/A	N/A	N/A	-12,594.21%	-421.73%	-147.54%	N/A
GMN GobiMin	-C$10.43M	-C$0.29	N/A	∞	N/A	83,354.28%	-13.01%	-3.82%	N/A
OLY Olympia Financial Group	C$24.45M	C$10.16	12.91	∞	N/A	23.82%	64.95%	35.88%	N/A
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	27.10	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AIM AIM ImmunoTech	N/A	N/A	N/A	N/A	N/A
GMN GobiMin	N/A	4.35%	N/A	N/A	N/A
OLY Olympia Financial Group	C$7.20	5.49%	N/A	70.86%	N/A
XLY Consumer Discretionary Select Sector SPDR Fund	$1.82	0.79%	N/A	N/A	N/A

Latest GMN, OLY, AIM, and XLY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/20/2025	OLY Olympia Financial Group	Monthly	C$0.60	5.76%	8/20/2025	8/29/2025	8/29/2025
7/22/2025	OLY Olympia Financial Group	Monthly	C$0.60	5.95%	7/22/2025	7/31/2025	7/31/2025
6/19/2025	OLY Olympia Financial Group	Monthly	C$0.60	6.28%	6/19/2025	6/30/2025	6/30/2025
5/21/2025	OLY Olympia Financial Group	Monthly	C$0.60	6.99%	5/21/2025	5/30/2025	5/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AIM AIM ImmunoTech	0.05	0.75	0.75
GMN GobiMin	0.58	33.63	31.98
OLY Olympia Financial Group	6.00	3.32	1.59
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AIM AIM ImmunoTech	12.02%
GMN GobiMin	N/A
OLY Olympia Financial Group	1.17%
XLY Consumer Discretionary Select Sector SPDR Fund	69.93%

Insider Ownership

Company	Insider Ownership
AIM AIM ImmunoTech	0.02%
GMN GobiMin	N/A
OLY Olympia Financial Group	34.63%
XLY Consumer Discretionary Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AIM AIM ImmunoTech	20	764,000	68.74 million	Not Optionable
GMN GobiMin	N/A	49.06 million	N/A	Not Optionable
OLY Olympia Financial Group	325	2.41 million	N/A	Not Optionable
XLY Consumer Discretionary Select Sector SPDR Fund	147,000	100.40 million	N/A	Not Optionable

GMN, OLY, AIM, and XLY Headlines

Recent News About These Companies

Lululemon, Wendy’s, Peloton Get Some Institutional Love As Hedge Funds Shuffle Consumer Stocks Deck

August 15 at 2:01 AM | msn.com

5 ETFs to Benefit if Fed Cuts Rate in September

August 11, 2025 | zacks.com

What Tariffs Mean for Your Sector Exposure

August 8, 2025 | msn.com

Should You Invest in the Consumer Discretionary Select Sector SPDR ETF (XLY)?

August 6, 2025 | zacks.com

Trump Tariff Blows Didn’t Stop These 3 Stocks From Defying Last Week’s Consumer Slump

August 4, 2025 | msn.com

Looking for Exposure to Amazon Stock (AMZN) Post Q2 Dip? Try These Two ETFs

August 2, 2025 | msn.com

Strong Start to Q2 Earnings Season: 4 Sector ETFs to Play

July 30, 2025 | zacks.com

4 Sector ETFs to Play on Improving Earnings Trends

July 28, 2025 | zacks.com

Earnings Scoreboard: 12 of 17 consumer cyclical stocks beat estimates last week

July 27, 2025 | msn.com

Consumer Durables: Overview, What They Are, Example

July 25, 2025 | fool.com

ETFs to Consider as Consumer Sentiment Improves in July

July 21, 2025 | zacks.com

Weekly Economic Snapshot: Consumer Spending Rebounds Despite Rising Inflation

July 21, 2025 | etftrends.comE

Consumer Stocks Post Weekly Gains As Retail Sales Rebound, Inflation Picks Up: Here Are The Top 3 Winners

July 21, 2025 | msn.com

The Market Rally Is Gaining Momentum—Don’t Get Left Behind (XLY)

...

July 17, 2025 | marketbeat.com

5 Sector ETFs Set to Power Q2 Earnings Growth

July 10, 2025 | zacks.com

S&P 500 consumer discretionary sector jumps 8.9% in Q2, Royal Caribbean Cruises, Carnival, Lululemon Athletica among top movers

July 3, 2025 | seekingalpha.com

Weekly Economic Snapshot: Record Highs Amid Rising Inflation & Conflicting Sentiment

June 30, 2025 | etftrends.comE

Norwegian Cruise Line Stock: Is NCLH Underperforming the Consumer Discretionary Sector?

June 26, 2025 | msn.com

Consumer Discretionary Select Sector SPDR ETF declares quarterly distribution of $0.4470

June 23, 2025 | msn.com

Amcor Stock: Is AMCR Underperforming the Consumer Discretionary Sector?

June 23, 2025 | finance.yahoo.com

Consumer Rebound Boosts Outlook for Discretionary ETFs

June 16, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

GMN, OLY, AIM, and XLY Company Descriptions

AIM ImmunoTech NYSE:AIM

$2.65 +0.08 (+3.11%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$2.66 +0.01 (+0.38%)

As of 08/15/2025 07:50 PM Eastern

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

GobiMin CVE:GMN

C$1.83 0.00 (0.00%)

As of 03/8/2023

GobiMin Inc., together with its subsidiaries, engages in investment in equity, debt, or other securities in China. The company operates in two segments, Investment Business and Mining Business. It is also involved in the property investment, holding, and leasing activities; and development, exploration, and exploitation of gold property, as well as provision of business and consultancy services. The company is based in Montreal, Canada. GobiMin Inc. operates as a subsidiary of Belmont Holdings Group Limited.

Olympia Financial Group TSE:OLY

C$131.20 +2.45 (+1.90%)

As of 08/15/2025 03:49 PM Eastern

Olympia Financial Group Inc is engaged in providing financial services. The company's operating segments are Private Health Services Plan division which markets, sells and administers health and dental benefits to business owners; Investment Account Services division specializes in registered account administration; The Currency and Global Payments division provides corporations and private clients a personalized service for buying and selling foreign currencies; The Exempt Edge division is focused on Onboarding fees; The Corporate and Shareholder Services division, which acts as a cost centre and the Corporate Division.

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

$229.04 -0.55 (-0.24%)

Closing price 08/15/2025 04:10 PM Eastern

Extended Trading

$229.02 -0.02 (-0.01%)

As of 08/15/2025 08:00 PM Eastern

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time